GenMark Diagnostics (GNMK) Updates Annual Revenue Guidance
6/18/2013 9:37:50 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today updated its annual revenue guidance for the year ending December 31, 2013. As a result of additional uncertainties relating to the future revenue contribution from its largest customer, together with persisting reimbursement and other challenges affecting the emerging pharmacogenomics market sector, the Company is updating its annual revenue guidance to approximately $30 million from its original estimate of approximately $35 million.
Help employers find you! Check out all the jobs and post your resume.